Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Aurora Cannabis Inc. (ACB $6.63)
- $6.63 P/E (TTM): 68.7X Cap: $372M
- View ACB Profile
- View Questions on ACB
-
Invictus MD Strategies Corp (GENE)
-
Australis Capital Inc (AUSA)
Q: My daughter holds the above cannabis stocks in her TFSA all,of which are offside between 13% ACB, AUSA 87% and GENE 40%. Are any of these worth holding or should she bail?
Q: Emerging companies in the Marijuana industry like these two need focus to progress in a positive way. What are your top 3-5 areas of attention that you would like to see and continue to research to make them a worthwhile investment opportunity in 2019 and beyond?
Q: Will Peter's fireside chat with Gene Simmons at the Moneyshow be archived somewhere or, if not, the subject of a blog or Financial Post article?
Insiders
Share Information
News and Media